Literature DB >> 15958454

Adjuvant treatment for early breast cancer.

I Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958454     DOI: 10.1093/annonc/mdi709

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.

Authors:  Eric A Ariazi; Joan S Lewis-Wambi; Shaun D Gill; Jennifer R Pyle; Jennifer L Ariazi; Helen R Kim; Catherine G N Sharma; Fernando Cordera; Heather A Shupp; Tianyu Li; V Craig Jordan
Journal:  J Steroid Biochem Mol Biol       Date:  2006-11-07       Impact factor: 4.292

2.  Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study).

Authors:  Ignasi Tusquets; Enrique Espinosa Arranz; Miguel Méndez; J Miquel Gil; José Luis Guallar; Núria Perulero
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.